Amgen Inc
(AMGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,090,000 | 6,717,000 | 6,552,000 | 5,893,000 | 7,264,000 |
| Depreciation Amortization | 5,592,000 | 4,071,000 | 3,417,000 | 3,398,000 | 3,601,000 |
| Income taxes - deferred | -1,228,000 | -1,273,000 | -1,198,000 | -453,000 | -287,000 |
| Accounts receivable | 441,000 | -1,015,000 | -746,000 | -429,000 | -427,000 |
| Accounts payable and accrued liabilities | 312,000 | -402,000 | 154,000 | -69,000 | 45,000 |
| Other Working Capital | 2,365,000 | -484,000 | -733,000 | -1,194,000 | -216,000 |
| Other Operating Activity | -82,000 | 857,000 | 2,275,000 | 2,115,000 | 517,000 |
| Operating Cash Flow | $11,490,000 | $8,471,000 | $9,721,000 | $9,261,000 | $10,497,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 1,672,000 | -1,369,000 | 4,334,000 | -1,499,000 |
| PPE Investments | -1,096,000 | -1,112,000 | -936,000 | -880,000 | -608,000 |
| Net Acquisitions | N/A | -26,989,000 | -3,839,000 | -2,529,000 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -3,219,000 |
| Other Investing Activity | 50,000 | 225,000 | 100,000 | -192,000 | -75,000 |
| Investing Cash Flow | $-1,046,000 | $-26,204,000 | $-6,044,000 | $733,000 | $-5,401,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 27,777,000 | 6,919,000 | 4,945,000 | 8,914,000 |
| Debt Repayment | -3,600,000 | -1,454,000 | 0 | -4,150,000 | -6,450,000 |
| Common Stock Repurchased | -200,000 | 0 | -6,360,000 | -4,975,000 | -3,486,000 |
| Dividend Paid | -4,832,000 | -4,556,000 | -4,196,000 | -4,013,000 | -3,755,000 |
| Other Financing Activity | -783,000 | -719,000 | -400,000 | -78,000 | -90,000 |
| Financing Cash Flow | $-9,415,000 | $21,048,000 | $-4,037,000 | $-8,271,000 | $-4,867,000 |
| Beginning Cash Position | 10,944,000 | 7,629,000 | 7,989,000 | 6,266,000 | 6,037,000 |
| End Cash Position | 11,973,000 | 10,944,000 | 7,629,000 | 7,989,000 | 6,266,000 |
| Net Cash Flow | $1,029,000 | $3,315,000 | $-360,000 | $1,723,000 | $229,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,490,000 | 8,471,000 | 9,721,000 | 9,261,000 | 10,497,000 |
| Capital Expenditure | -1,096,000 | -1,112,000 | -936,000 | -880,000 | -608,000 |
| Free Cash Flow | 10,394,000 | 7,359,000 | 8,785,000 | 8,381,000 | 9,889,000 |